124 related articles for article (PubMed ID: 14693240)
1. Prognostic significance of p34cdc2 expression in tongue squamous cell carcinoma.
Wada S; Yue L; Furuta I
Oral Oncol; 2004 Feb; 40(2):164-9. PubMed ID: 14693240
[TBL] [Abstract][Full Text] [Related]
2. Prognostic value of p53 expression and histopathological parameters in squamous cell carcinoma of oral tongue.
Unal OF; Ayhan A; Hoşal AS
J Laryngol Otol; 1999 May; 113(5):446-50. PubMed ID: 10505159
[TBL] [Abstract][Full Text] [Related]
3. Peroxiredoxin I expression in tongue squamous cell carcinomas as involved in tumor recurrence.
Yanagawa T; Omura K; Harada H; Ishii T; Uwayama J; Nakaso K; Iwasa S; Koyama Y; Onizawa K; Yusa H; Yoshida H
Int J Oral Maxillofac Surg; 2005 Dec; 34(8):915-20. PubMed ID: 15955662
[TBL] [Abstract][Full Text] [Related]
4. [Expression of inducible nitric oxide synthase mRNA in squamous cell carcinoma of tongue].
Chen WL; Zeng SG; Li HG; Huang HZ; Pan CB
Ai Zheng; 2002 Mar; 21(3):314-8. PubMed ID: 12452003
[TBL] [Abstract][Full Text] [Related]
5. Tumor budding correlates with occult cervical lymph node metastasis and poor prognosis in clinical early-stage tongue squamous cell carcinoma.
Xie N; Wang C; Liu X; Li R; Hou J; Chen X; Huang H
J Oral Pathol Med; 2015 Apr; 44(4):266-72. PubMed ID: 25169851
[TBL] [Abstract][Full Text] [Related]
6. Predictive markers for late cervical metastasis in stage I and II invasive squamous cell carcinoma of the oral tongue.
Lim SC; Zhang S; Ishii G; Endoh Y; Kodama K; Miyamoto S; Hayashi R; Ebihara S; Cho JS; Ochiai A
Clin Cancer Res; 2004 Jan; 10(1 Pt 1):166-72. PubMed ID: 14734465
[TBL] [Abstract][Full Text] [Related]
7. IMP3 is a novel biomarker to predict metastasis and prognosis of tongue squamous cell carcinoma.
Li HG; Han JJ; Huang ZQ; Wang L; Chen WL; Shen XM
J Craniofac Surg; 2011 Nov; 22(6):2022-5. PubMed ID: 22067851
[TBL] [Abstract][Full Text] [Related]
8. Fatty acid synthase expression in squamous cell carcinoma of the tongue: clinicopathological findings.
Silva SD; Perez DE; Nishimoto IN; Alves FA; Pinto CA; Kowalski LP; Graner E
Oral Dis; 2008 May; 14(4):376-82. PubMed ID: 18410580
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value of cell motility activation factors in patients with tongue squamous cell carcinoma.
Endo K; Shirai A; Furukawa M; Yoshizaki T
Hum Pathol; 2006 Aug; 37(8):1111-6. PubMed ID: 16867875
[TBL] [Abstract][Full Text] [Related]
10. Histone deacetylase-1 and -2 expression in mobile tongue squamous cell carcinoma: associations with clinicopathological parameters and patients survival.
Theocharis S; Klijanienko J; Giaginis C; Rodriguez J; Jouffroy T; Girod A; Alexandrou P; Sastre-Garau X
J Oral Pathol Med; 2011 Oct; 40(9):706-14. PubMed ID: 21457345
[TBL] [Abstract][Full Text] [Related]
11. Prediction of delayed neck metastasis in patients with stage I/II squamous cell carcinoma of the tongue.
Okamoto M; Nishimine M; Kishi M; Kirita T; Sugimura M; Nakamura M; Konishi N
J Oral Pathol Med; 2002 Apr; 31(4):227-33. PubMed ID: 12076326
[TBL] [Abstract][Full Text] [Related]
12. [Postoperative recurrence-related factors of 125 patients with cT1-2N0 squamous cell carcinoma of the oral tongue].
Han JM; Wu GH; Zeng ZY; Chen FJ; Chen WK; Li H; Song M; Sun CZ
Ai Zheng; 2007 Jun; 26(6):661-5. PubMed ID: 17562277
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of lymph node density in squamous cell carcinoma of the tongue.
Ong W; Zhao R; Lui B; Tan W; Ebrahimi A; Clark JR; Soo KC; Tan NC; Tan HK; Iyer NG
Head Neck; 2016 Apr; 38 Suppl 1():E859-66. PubMed ID: 25917601
[TBL] [Abstract][Full Text] [Related]
14. The prognostic significance of p34cdc2 and cyclin D1 protein expression in prostate adenocarcinoma.
Kallakury BV; Sheehan CE; Ambros RA; Fisher HA; Kaufman RP; Ross JS
Cancer; 1997 Aug; 80(4):753-63. PubMed ID: 9264360
[TBL] [Abstract][Full Text] [Related]
15. Clinico-pathological predictive factors in squamous cell carcinoma of the tongue and the floor of the mouth.
Gontarz M; Wyszynska-Pawelec G; Zapala J
Folia Med Cracov; 2013; 53(2):73-86. PubMed ID: 24858459
[TBL] [Abstract][Full Text] [Related]
16. Expression and clinical significance of SPARC in clinical stage II tongue squamous cell carcinoma.
Zhang J; Zhang Q; Zhang Q; Liu XK; Li CQ; Guo ZM
Ai Zheng; 2009 Jan; 28(1):68-71. PubMed ID: 19448421
[TBL] [Abstract][Full Text] [Related]
17. Cyclo-oxygenase-2 expression is associated with vascular endothelial growth factor C expression and lymph node metastasis in oral squamous cell carcinoma.
Kono M; Watanabe M; Abukawa H; Hasegawa O; Satomi T; Chikazu D
J Oral Maxillofac Surg; 2013 Oct; 71(10):1694-702. PubMed ID: 23809761
[TBL] [Abstract][Full Text] [Related]
18. Immunoexpression of matrix metalloproteinase-2 and matrix metalloproteinase-9 in the metastasis of squamous cell carcinoma of the human tongue.
Zhou CX; Gao Y; Johnson NW; Gao J
Aust Dent J; 2010 Dec; 55(4):385-9. PubMed ID: 21174909
[TBL] [Abstract][Full Text] [Related]
19. High expression of the histone demethylase LSD1 associates with cancer cell proliferation and unfavorable prognosis in tongue cancer.
Yuan C; Li Z; Qi B; Zhang W; Cheng J; Wang Y
J Oral Pathol Med; 2015 Feb; 44(2):159-65. PubMed ID: 25040359
[TBL] [Abstract][Full Text] [Related]
20. The high prognostic value of the histologic grade at the deep invasive front of tongue squamous cell carcinoma.
Kurokawa H; Zhang M; Matsumoto S; Yamashita Y; Tomoyose T; Tanaka T; Fukuyama H; Takahashi T
J Oral Pathol Med; 2005 Jul; 34(6):329-33. PubMed ID: 15946179
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
